dihexa pnb-0408 c-met hgfr activator MET – an ideal target for antibody drug conjugate therapy, plus nivolumab dihexa chemical properties solubility stability
dihexa chemical properties solubility stability Cabozantinib hydrochloride c Met inhibitor CAS 1817759 42 4 Pancreatic Cancer Treatment Targeting the HGF c MET Pathway: The MEK Inhibitor Trametinib dihexa solution stability data Disguised Alpha Dihexa (PNB 0408) c Met HGFR Activator Dimethyl fumarate Nrf2 Activator MedChemExpress dihexa pnb 0408 Smart Brothers Dihexa PNB 0408 30 caps
Pay in 4 interest-free payments of $7.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




